Health Services

Natera, Inc. CEO pay

Matthew Rabinowitz, President Clinical Diagnostics. Fiscal year 2025, as reported to the SEC.

Total compensation

$11.3M

$11,283,382 for fiscal 2025: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2026-04-23SEC accession number 0001104659-26-047770

In context

The median chief executive among 23 Health Services companies with $1B – $10B in revenue was paid $7.2M. The middle half ranged from $3.4M to $11.1M.

Matthew Rabinowitz's total is above that median.

See how your pay compares to Natera, Inc.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: Natera, Inc.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2025. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-10-28. Not financial, legal or compensation-consulting advice.